NCT06582524 - Pegzilarginase in Subjects <24 Months Old With Arginase 1 Deficiency | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 30, 2024

Primary Completion Date

June 17, 2025

Study Completion Date

October 1, 2025

Conditions

Arginase 1 Deficiency

Interventions

DRUG

Pegzilarginase

SC administration of pegzilarginase over 12 weeks in subjects with ARG1-D who are \< 24 months of age

Trial Locations (3)

Univ. Klinik für Kinder- und Jugendheilkunde Medizinische Universität, Graz

Unidade de Doenças Metabólicas Pediatria, Hospital Santa Maria, Lisbon

Bradford Royal Infirmary Duckworth Lane, Bradford